BackRecordati Industria Chimica e Farmaceutica S.p.A. Overview

Recordati Industria Chimica e Farmaceutica S.p.A. Total Liabilities

Track Recordati Industria Chimica e Farmaceutica S.p.A.'s total liabilities ($3.1B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$3.12B
↓ 7.51% YoYΔ $-253.24M vs prior year quarter

Peer trimmed avg / median

Loading

Recordati Industria Chimica e Farmaceutica S.p.A. Total Liabilities History

Loading

Recordati Industria Chimica e Farmaceutica S.p.A. vs. peers: Total Liabilities Comparison

Loading

Recordati Industria Chimica e Farmaceutica S.p.A. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) FAQ

As of the most recent data (September 2026), RCDTF shows a total liabilities of $3.1B. That compares with $3.4B in the prior-year period — down 7.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RCDTF's total liabilities is now $3.1B (was $3.4B) — a 7.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Recordati Industria Chimica e Farmaceutica S.p.A. is outperforming or lagging.

Tracking RCDTF's total liabilities over time shows whether Recordati Industria Chimica e Farmaceutica S.p.A. is scaling, shrinking, or reshaping that part of the business. The current reading is $3.1B That compares with $3.4B in the prior-year period — down 7.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Recordati Industria Chimica e Farmaceutica S.p.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $3.1B) with ownership activity and broader fundamentals.